|Podcasts|September 3, 2021

What Strategies Should Pharma and Biotech Firms Take to Adapt to the Evolving Central Lab Landscape in Post-COVID Era

Author(s)Frontage Labs

On a global scale, Frontage Central Lab Business is assisting clients with their drug development needs across all clinical phases. In this podcast, the Frontage Central lab team will discuss some of the best practices to keep in mind when choosing a lab partner for PK/PD and routine/specialty central lab support.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Articles

Unlock Commercial Growth through Data-Driven Patient and HCP Insights Podcast
May 2nd 2025
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025
Thinking Big for Small and Mid-Sized Biotechs: How Applying Modeling and Simulation Technologies Can Improve Drug Development
January 6th 2023
The Evolving Relationship Between Sponsors and the Contract Research Organizations
December 8th 2022
The MDR: Navigating Europe’s New Standard for Medical Device Safety
October 25th 2022
The impact an eClinical Supply Chain Management platform can have on your next clinical trial
September 19th 2022

Trending on Applied Clinical Trials Online

Subcutaneous Saphnelo Shows Positive Phase III Results in Systemic Lupus Erythematosus

Phase IV Trial Shows Strong Immune Response from Moderna’s Updated Spikevax Against LP.8.1 Variant of COVID-19

ACT Brief: Policy Shifts, FDA Inspections, and Tariffs Pose New Challenges for Clinical Trials

IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes

Enhancing Clinical Trial Data Accuracy Through the IQVIA and Veeva Partnership

© 2025 MJH Life Sciences^®

All rights reserved.